Clinical Trial Update: Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial comparing chidamide plus exemestane (± goserelin) against neoadjuvant chemotherapy in stage II-III HR-positive/HER2-negative breast cancer is l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Chidamide (chidamide)
• Exemestane (Exemestane)
• Goserelin (Goserelin)

Snippet

Sponsor: Shengjing Hospital | Conditions: Breast Neoplasms | Phase 2, Phase 3 | Status: UNKNOWN